Physician

Andrew Edward Schwentker, MD

According to 2025 Medicare claims, Andrew Schwentker, MD (NPI: 1649232331) practices internal medicine in the Winchester, VA-WV market, with the plurality of this provider's patient population coming from Winchester City, VA. This provider's primary affiliated billing organization is WINCHESTER INTERNAL MEDICINE, INC (NPI: 1730130667; TIN: 540952457) and primary practice location at 22601-2872. Schwentker is affiliated with the Aledade 94 VA MSSP Enhanced (ACO ID: A4996), Sound Physicians Long Term Care Management, LLC (ACO ID: A5220), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Schwentker's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 806 traditional Medicare patients, billed 12,607 HCPCS/CPT codes, and received $396,410 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 11,905 prescription claims across 829 beneficiaries totaling $1,007,085 in drug costs, led by Eliquis (Apixaban). DME data shows 575 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $43,810 to $48,694.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,790	13,788	$382,872
2016	1,342	13,440	$399,973
2017	1,544	13,257	$371,460
2018	1,196	12,414	$377,110
2019	1,221	11,429	$360,680
2020	1,147	9,743	$303,992
2021	976	10,674	$345,297
2022	887	10,698	$367,816
2023	851	11,230	$390,210
2024	806	12,607	$396,410

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	610	11,965	$723,703
2016	588	12,232	$732,988
2017	580	11,602	$704,309
2018	613	11,389	$748,548
2019	614	10,152	$785,218
2020	606	8,836	$707,801
2021	559	8,681	$722,819
2022	652	9,401	$900,352
2023	725	10,499	$1,039,301
2024	829	11,905	$1,007,085

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	258	766	$26,781
2016	255	798	$21,533
2017	252	634	$12,575
2018	287	783	$19,606
2019	233	626	$18,102
2020	276	635	$22,975
2021	253	668	$24,692
2022	230	582	$30,464
2023	234	782	$45,366
2024	192	575	$43,307

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	594	594	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	586	1,321	$83
80061	Blood test, lipids (cholesterol and triglycerides)	704	1,265	$13
80053	Blood test, comprehensive group of blood chemicals	693	1,026	$10
36415	Insertion of needle into vein for collection of blood sample	735	1,604	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	285	13,588	$260,158
Jardiance	Empagliflozin	181	8,057	$145,078
Ozempic	Semaglutide	85	2,598	$86,286
Januvia	Sitagliptin Phosphate	44	2,700	$45,487
Xarelto	Rivaroxaban	43	2,449	$42,928

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	12	41	$20,801
A7031	Face mask interface, replacement for full face mask, each	N	18	49	$4,970
A7030	Full face mask used with positive airway pressure device, each	N	18	51	$4,598
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	24	$2,300
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	20	52	$2,109

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Andrew Edward Schwentker, MD?

Tedicare shows public-source Medicare data for Andrew Edward Schwentker, MD (NPI 1649232331), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Edward Schwentker, MD have ACO affiliation data?

Andrew Edward Schwentker, MD is shown with ACO affiliation data for Aledade 94 VA MSSP Enhanced (MSSP, ACO ID A4996), Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Andrew Edward Schwentker, MD?

Andrew Edward Schwentker, MD is linked to WINCHESTER INTERNAL MEDICINE, INC (billing NPI 1730130667) in the available physician profile data.

Does Andrew Edward Schwentker, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.